Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDGenerate Biomedicines Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | -$0.58 | -$0.47 | -$0.51 |
| Q2 2026 | 3 | -$0.54 | -$0.49 | -$0.51 |
| Q3 2026 | 3 | -$0.58 | -$0.52 | -$0.54 |
| Q4 2026 | 1 | -$0.80 | -$0.39 | -$0.57 |
| Q1 2027 | 1 | -$0.73 | -$0.35 | -$0.52 |
| Q2 2027 | 1 | -$0.69 | -$0.33 | -$0.49 |
| Q3 2027 | 1 | -$0.68 | -$0.33 | -$0.49 |
| Q4 2027 | 1 | -$0.68 | -$0.33 | -$0.49 |
Generate Biomedicines Inc Earnings Date And Information
Generate Biomedicines Inc last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 7.22 M for the quarter and had revenue of 31.89 M for the year. Generate Biomedicines Inc has generated $-5 earnings per share over the last year ($-4.98 diluted earnings per share) and currently has a price-to-earnings ratio of -3.12. Generate Biomedicines Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Generate Biomedicines Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/30/2026 | Q1 2026 | N/A | -$0.54 | N/A | $5.28 M | $7.22 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Generate Biomedicines Inc Earnings: FAQ's
The conference call for Generate Biomedicines Inc's latest earnings report can be listened to online.
The conference call transcript for Generate Biomedicines Inc's latest earnings report can be read online.
Generate Biomedicines Inc (:GENB) has a recorded annual revenue of $31.89 M.
Generate Biomedicines Inc (:GENB) has a recorded net income of $-203,154,000.Generate Biomedicines Inc has generated $-4.98 earnings per share over the last four quarters.
Generate Biomedicines Inc (:GENB) has a price-to-earnings ratio of -3.12 and price/earnings-to-growth ratio is -0.03.